Skip to main content
. 2017 Feb 8;4(1):e000127. doi: 10.1136/bmjgast-2016-000127

Figure 1.

Figure 1

(A) Refractory pouchitis with a PDAI of 10, (B) pouch with normal mucosa and PDAI of 4 in week 20 after VDZ; (C) histological aspect of chronic refractory pouchitis, (D) histological aspect of uninflamed pouch mucosa after therapy. PDAI, Pouchitis Disease Activity Index; VDZ, vedolizumab.